Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.cegh.2020.07.006

http://scihub22266oqcxt.onion/10.1016/j.cegh.2020.07.006
suck pdf from google scholar
33521390!7831805!33521390
unlimited free pdf from europmc33521390    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid33521390      Clin+Epidemiol+Glob+Health 2021 ; 9 (ä): 90-98
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Antivirals for COVID-19: A critical review #MMPMID33521390
  • Frediansyah A; Tiwari R; Sharun K; Dhama K; Harapan H
  • Clin Epidemiol Glob Health 2021[Jan]; 9 (ä): 90-98 PMID33521390show ga
  • No specific drugs have been approved for coronavirus disease 2019 (COVID-19) to date as the development of antivirals usually requires time. Therefore, assessment and use of currently available antiviral drugs is critical for a timely response to the current pandemic. Here, we have reviewed anti-SARS-CoV-2 potencies of available antiviral drug groups such as fusion inhibitors, protease inhibitors, neuraminidase inhibitors, and M2 ion-channel protein blockers. Although clinical trials to assess the efficacy of these antivirals are ongoing, this review highlights important information including docking and modeling analyses, in vitro studies, as well as results from clinical uses of these antivirals against COVID-19 pandemic.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box